Aggressive NK-cell leukemia

Clinical trials for Aggressive NK-cell leukemia explained in plain language.

Never miss a new study

Get alerted when new Aggressive NK-cell leukemia trials appear

Sign up with your email to follow new studies for Aggressive NK-cell leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Completed 1

New drug duo shows promise for rare blood cancer

Disease control Completed

This completed phase 2 study tested a combination of two drugs, isatuximab and cemiplimab, in 37 adults with relapsed or refractory NK/T-cell lymphoma, a rare and aggressive blood cancer. The goal was to see if the combination could shrink tumors or stop the cancer from growing. …

Matched conditions: AGGRESSIVE NK-CELL LEUKEMIA

Phase 2 • Sponsor: Won Seog Kim • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

Aggressive NK-cell leukemia

Get alerted when new Aggressive NK-cell leukemia trials appear

New drug duo shows promise for rare blood cancer